Atorvastatin is also renoprotective against glomerulosclerosis and proteinuria in SS HTN by reducing NOX/ROS, plasma F2-isoprostane, and TGF-β1 activity and restoring eNOS activity and NO levels [363]. Here, NOS3 is linked to glomerulosclerosis.